Ligand Pharmaceuticals
LGND
#2688
Rank
โ‚น604.25 B
Marketcap
โ‚น30,311
Share price
0.61%
Change (1 day)
85.94%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): โ‚น22.04 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.29 Billion. In 2025 the company made an earning of โ‚น15.53 Billion, an increase over its 2024 earnings that were of โ‚น0.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น22.04 B41.85%
2025 โ‚น15.53 B2848.57%
2024 โ‚น0.52 B-91.37%
2023 โ‚น6.10 B-7.59%
2022 โ‚น6.60 B4%
2021 โ‚น6.35 B296.42%
2020 โ‚น1.60 B-97.97%
2019 โ‚น79.02 B275.62%
2018 โ‚น21.03 B237.48%
2017 โ‚น6.23 B49.05%
2016 โ‚น4.18 B55.41%
2015 โ‚น2.69 B36.87%
2014 โ‚น1.96 B29.59%
2013 โ‚น1.51 B1309.35%
2012 โ‚น0.10 B-43.97%
2011 โ‚น0.19 B-113.19%
2010 -โ‚น1.46 Billion59.86%
2009 -โ‚น0.92 Billion-61.33%
2008 -โ‚น2.36 Billion-58.75%
2007 -โ‚น5.72 Billion20.52%
2006 -โ‚น4.75 Billion81.27%
2005 -โ‚น2.62 Billion
2003 -โ‚น1.83 Billion-20.6%
2002 -โ‚น2.3 Billion4.38%
2001 -โ‚น2.2 Billion-48.83%
2000 -โ‚น4.3 Billion-19.74%
1999 -โ‚น5.35 Billion-19.06%
1998 -โ‚น6.61 Billion126.71%
1997 -โ‚น2.92 Billion-5.83%
1996 -โ‚น3.1 Billion136.23%
1995 -โ‚น1.32 Billion-33.97%
1994 -โ‚น1.99 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.488 T 10,634.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น655.75 B 2,728.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.189 T 13,660.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น976.64 B 4,113.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น45.86 Billion-297.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น730.08 B 3,049.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.130 T 4,778.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น749.03 B 3,131.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-โ‚น5.88 Billion-125.35%๐Ÿ‡บ๐Ÿ‡ธ USA